Hermansky-Pudlak syndrome: severe colitis and good response to infliximab.
Felipez
L M
LM
Department of Pediatrics, Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Chicago, IL, USA.
Gokhale
R
R
Guandalini
S
S
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003092:Colitis / Q000188:drug therapy* / Q000209:etiology; D022861:Hermanski-Pudlak Syndrome / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab